Binding Database

16 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

1995900

Romazarit: a potential disease-modifying antirheumatic drug.

Roche Products

2491889

Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenols.

Boehringer Ingelheim Pharmaceuticals

3104589

Benzimidazole derivatives with atypical antiinflammatory activity.

TBA

16220969

219

Designed multiple ligands. An emerging drug discovery paradigm.

Organon Laboratories

1635053

5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.

Wyeth-Ayerst Research

3918169

Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.

TBA

1-Phenyl-[2H]-tetrahydropyridazin-3-one, A-53612, a selective orally active 5-lipoxygenase inhibitor

TBA

32142276

Distribution of Bibenzyls, Prenyl Bibenzyls, Bis-bibenzyls, and Terpenoids in the Liverwort Genus

Tokushima Bunri University

8254620

3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.

Tokushima Bunri University

8246226

Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.

Ciba-Geigy

8648609

Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases.

Vanderbilt University School of Medicine

3669017

Phenylephrine derivatives as leukotriene D4 antagonists.

Wyeth Laboratories

3346867

Acetohydroxamic acids as potent, selective, orally active 5-lipoxygenase inhibitors.

Wellcome Research Laboratories

29031075

Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.

Damanhour University

2113949

126

Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.

Boehringer Ingelheim Pharmaceuticals